The Markey Cancer Center (MCC) is directed by B. Mark Evers, MD with the assistance of nationally recognized leaders in cancer research, prevention and clinical care. Senior Leadership of the MCC includes: Susanne M. Arnold, MD (Associate Director for Clinical Translation);David M. Gosky, MA, MBA (Associate Director for Administration);Daret St. Clair, PhD (Associate Director for Basic Research) and Thomas Tucker, PhD, MPH (Associate Director for Cancer Prevention and Control). This highly experienced Senior Leadership team works together to ensure consistency in the shared vision and goals of the MCC;to develop synergistic and highly collaborative interactions among the basic, translational and clinical components of the Center;to plan proactive approaches to the development of the research base and resources;to effectively leverage all available resources at the University of Kentucky and at the state and national levels;to engage in community outreach and philanthropy;and to oversee all activities of the MCC. This Senior Leadership team meets several times a month in some capacity (i.e., in the context of various MCC Board/Committee/Council meetings, one-on-one with the Director, and bi-weekly as a Director's Council). They provide critical advice and recommendations to the Director based on those interactions. All final authority for decisions on behalf of the MCC resides with the Director.
Support is requested for several members of the MCC Senior Leadership team who provide advice and recommendations to the Director regarding the strategic planning and evaluation of the Center's efforts.
|Starr, Marlene E; Steele, Allison M; Cohen, Donald A et al. (2016) Short-Term Dietary Restriction Rescues Mice From Lethal Abdominal Sepsis and Endotoxemia and Reduces the Inflammatory/Coagulant Potential of Adipose Tissue. Crit Care Med 44:e509-19|
|Sharma, Ashwani; Haque, Farzin; Pi, Fengmei et al. (2016) Controllable self-assembly of RNA dendrimers. Nanomedicine 12:835-44|
|Li, Hui; Zhang, Kaiming; Pi, Fengmei et al. (2016) Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting. Adv Mater 28:7501-7|
|Jiang, Kai; Liu, Yajuan; Fan, Junkai et al. (2016) PI(4)P Promotes Phosphorylation and Conformational Change of Smoothened through Interaction with Its C-terminal Tail. PLoS Biol 14:e1002375|
|Klimyte, Edita M; Smith, Stacy E; Oreste, Pasqua et al. (2016) Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues. J Virol 90:9237-50|
|Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74|
|Stewart, Rachel L; West, Dava; Wang, Chi et al. (2016) Elevated integrin Î±6Î²4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer. Hum Pathol 54:174-83|
|Stewart, Rachel L; Carpenter, Brittany L; West, Dava S et al. (2016) S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide. Oncotarget 7:34630-42|
|Khisamutdinov, Emil F; Jasinski, Daniel L; Li, Hui et al. (2016) Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs. Adv Mater 28:10079-10087|
|Li, Jing; Song, Jun; Weiss, Heidi L et al. (2016) Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells. Mol Endocrinol 30:26-36|
Showing the most recent 10 out of 177 publications